Omega-3 Fatty Acids Supplementation Improves Early-stage Diabetic Nephropathy and Subclinical Atherosclerosis in Pediatric Patients With Type 1 Diabetes
Omega-3 Fatty Acids Supplementation Improves Early-stage Diabetic Nephropathy and Subclinical Atherosclerosis in Pediatric Patients With Type 1 Diabetes
NCT ID: NCT05980026 Phase: NA Status: COMPLETED Enrollment: 70 Completion: 2023-01-14
Conditions
Diabetes Mellitus, Type 1
Interventions
oral omega-3 fatty acids supplementation, Placebo
Summary
The investigators conducted this randomized-controlled trial to assess the effect of oral omega-3 supplementation on glycemic control, lipid profile, albuminuria level, kidney injury molecule-1 (KIM-1) and carotid intima media thickness (CIMT) to participants who were pediatric patients with T1DM and diabetic nephropathy.
Primary Outcome
change in UACR (mg/g creatinine) level